Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tan

Showing results (841-850 of 1,101) with videos related to

Pageof 111
Sort By:
Journal of Occupational Rehabilitation|February 18, 2011
Occupational rehabilitation in Singapore and MalaysiaKay-Fei Chan, Charlie W C Tan, Doreen S C Yeo, et al.
International Journal of Antimicrobial Agents|June 20, 2017
Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship teamTat Ming Ng, Vanessa Y Phang, Barnaby Young, et al.
Asian-Australasian Journal of Animal Sciences|March 9, 2016
Effects of Three Feeding Systems on Production Performance, Rumen Fermentation and Rumen Digesta Particle Structure of Beef CattleY F Liu, F F Sun, F C Wan, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Analytica Chimica Acta|October 8, 2018
Recent advances in the applications of metabolomics in eye researchLiyan Chen, Yan Gao, Louis Zizhao Wang, et al.
BMC Cancer|December 26, 2018
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
BMC Cancer|December 5, 2018
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.
Annals of Hematology|April 27, 2011
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxisYu Xuan Koo, Matthew Tay, Yii Ean Teh, et al.
Investigative Ophthalmology & Visual Science|January 6, 2021
Diabetic Macular Ischemia: Influence of Optical Coherence Tomography Angiography Parameters on Changes in Functional Outcomes Over One YearAndrew S H Tsai, Janice Marie Jordan-Yu, Alfred T L Gan, et al.
Pageof 111

Showing results (841-850 of 1,101) with videos related to

Sort By:
Pageof 111
Journal of Occupational Rehabilitation|February 18, 2011
Occupational rehabilitation in Singapore and MalaysiaKay-Fei Chan, Charlie W C Tan, Doreen S C Yeo, et al.
International Journal of Antimicrobial Agents|June 20, 2017
Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship teamTat Ming Ng, Vanessa Y Phang, Barnaby Young, et al.
Asian-Australasian Journal of Animal Sciences|March 9, 2016
Effects of Three Feeding Systems on Production Performance, Rumen Fermentation and Rumen Digesta Particle Structure of Beef CattleY F Liu, F F Sun, F C Wan, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Analytica Chimica Acta|October 8, 2018
Recent advances in the applications of metabolomics in eye researchLiyan Chen, Yan Gao, Louis Zizhao Wang, et al.
BMC Cancer|December 26, 2018
Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
BMC Cancer|December 5, 2018
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesWan-Ling Tan, Quan Sing Ng, Cindy Lim, et al.
Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.
Annals of Hematology|April 27, 2011
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxisYu Xuan Koo, Matthew Tay, Yii Ean Teh, et al.
Investigative Ophthalmology & Visual Science|January 6, 2021
Diabetic Macular Ischemia: Influence of Optical Coherence Tomography Angiography Parameters on Changes in Functional Outcomes Over One YearAndrew S H Tsai, Janice Marie Jordan-Yu, Alfred T L Gan, et al.
Pageof 111